NCCN: National Comprehensive Cancer Network Annual Conference

At the annual meeting of the National Comprehensive Cancer Network (NCCN), experts discuss updates and key issues for select NCCN Guidelines, new and emerging therapies, and more, along with special sessions of interest to the care team, such as barriers to care and practice.

Why White Bagging Is a Symptom of High Drug Costs, and What States Are Doing

April 03, 2022

Article

Many oncologists oppose white bagging because they prefer to be able to adjust doses during a visit based on lab reports taken that day.

Early Treatment Matters More Than Ever in Multiple Myeloma, Kumar Says

April 02, 2022

Article

Whether a patient is refractory to initial treatment dictates the future course of care.

CDK4/6 Inhibitors, SERDs, and More in NCCN Talk on Breast Cancer Updates

April 01, 2022

Article

NCCN guidelines are no longer “a group of monotherapy choices,” but selections that feature partners for endocrine therapy, highlighted William J. Gradishar, MD, of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Cancer Care Closer to Home—or at Home—Is Worth Extra Effort, NCCN Panelists Say

April 01, 2022

Article

From taking part in clinical research at a local location to foregoing aggressive therapy in favor of quality of life, patients with cancer are seeking new options, said panelists at the 2022 Annual Conference of the National Comprehensive Cancer Network (NCCN).

The Expanding Landscape of Immunotherapy in Urothelial Bladder Cancer

March 25, 2021

Article

At the National Comprehensive Cancer Network Annual Conference, Arlene O. Siefker-Radtke, MD, discussed immune checkpoint inhibitors and their potential in urothelial bladder cancer.

Many Options, Many Updates to NCCN Guidelines in Multiple Myeloma

March 24, 2021

Article

Updates to the NCCN Guidelines in multiple myeloma reflect recent trial results, giving clinicians and patients many choices.

Better Record “Integration” Would Boost Links Between Oncologists, Primary Care

March 21, 2021

Article

A panel at the NCCN Virtual Annual Meeting finds that while primary care physicians and oncologists can share information, records may not be well integrated and in easy-to-use formats.

Looking at Long-term Results, New Opportunities With CAR T-Cell Therapies

March 20, 2021

Article

Penn Medicine's Stephen Schuster, MD, offers an overview of an eventful year in CAR T-cell therapy at the NCCN Virtual Annual Meeting.

NCCN Panel Discusses Challenges, Potential Solutions for Racial Disparities in Cancer Care

March 20, 2021

Article

A keynote session at the NCCN Virtual Annual Conference brought a panel of patient advocates and experts together for a timely and necessary discussion about strategies to reduce racial disparities in oncology.

Benefits and Challenges of ePRO Implementation in Oncology

March 19, 2021

Article

During a session at the National Comprehensive Cancer Network (NCCN) annual virtual conference, the payer perspective and physician experiences with PRO systems in both the community and academic medical center settings took center stage.